$PFX
PhenixFIN Corp Stock $pfx

$pfx Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024065749 Filed on August 06, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q3
Revenue		$1.980M	$5.678M
YoY Change		62.46%	11.43%
Cost Of Revenue		$1.722M	$1.502M
YoY Change		21.67%	24.88%
Gross Profit		$4.513M	$4.176M
YoY Change		31.82%	7.28%
Gross Profit Margin		227.92%	73.55%
Selling, General & Admin		$2.533M	$2.308M
YoY Change		14.89%	14.29%
% of Gross Profit		56.13%	55.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$127.0K
YoY Change		53.01%
% of Gross Profit		2.81%
Operating Expenses		$2.533M	$2.308M
YoY Change		14.89%	14.29%
Operating Profit		$1.980M	$1.868M
YoY Change		62.46%	-0.27%
Interest Expense		$1.722M	$5.473M
YoY Change		-77.63%	-183.86%
% of Operating Profit		86.96%	292.99%
Other Income/Expense, Net		$200.0K
YoY Change		0.0%
Pretax Income		$2.609M	$7.342M
YoY Change		-70.74%	-257.77%
Income Tax
% Of Pretax Income
Net Earnings		$2.609M	$7.342M
YoY Change		-70.74%	-257.77%
Net Earnings / Revenue		131.76%	129.3%
Basic Earnings Per Share		$1.29
Diluted Earnings Per Share		$1.29	$3.53
COMMON SHARES
Basic Shares Outstanding	2.020M shares	2.020M shares	2.089M shares
Diluted Shares Outstanding		2.020M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$103.0M	$5.988M
YoY Change		846.91%	-73.7%
Cash & Equivalents	$67.60M	$8.900M	$6.000M
Short-Term Investments		$94.09M	$79.06M
Other Short-Term Assets		$101.1K	$199.0K
YoY Change		783.92%	-59.31%
Inventory
Prepaid Expenses
Receivables		$1.715M	$4.911M
Other Receivables	$65.84K	$206.0K	$31.43K
Total Short-Term Assets		$11.56M	$11.70M
YoY Change		-6.63%	-52.58%
LONG-TERM ASSETS
Property, Plant & Equipment		$353.4K	$449.8K
YoY Change		-14.01%	-12.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$233.7M	$226.5M
YoY Change		6.86%	17.36%
Other Assets		$410.6K	$833.0K
YoY Change		-33.29%	-30.16%
Total Long-Term Assets		$234.7M	$228.0M
YoY Change		6.67%	17.4%
TOTAL ASSETS
Total Short-Term Assets		$11.56M	$11.70M
Total Long-Term Assets		$234.7M	$228.0M
Total Assets	$302.8M	$246.3M	$239.7M
YoY Change	26.31%	5.96%	9.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$5.808M	$7.190M
YoY Change		187.79%	-56.56%
Accrued Expenses		$847.1K	$1.123M
YoY Change		-25.25%	4.59%
Deferred Revenue			$421.7K
YoY Change
Short-Term Debt		$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$6.799M	$8.313M
YoY Change		-17.79%	160.68%
LONG-TERM LIABILITIES
Long-Term Debt		$85.29M	$84.25M
YoY Change		1.59%	8.07%
Other Long-Term Liabilities			$421.7K
YoY Change			28.62%
Total Long-Term Liabilities		$85.29M	$84.67M
YoY Change		1.28%	8.15%
TOTAL LIABILITIES
Total Short-Term Liabilities		$6.799M	$8.313M
Total Long-Term Liabilities		$85.29M	$84.67M
Total Liabilities	$142.4M	$92.09M	$92.99M
YoY Change	53.19%	-0.43%	-5.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$544.6M	-$538.2M	-$548.1M
YoY Change	-0.64%	0.61%	-1.16%
Common Stock	$704.9M	$692.4M	$694.8M
YoY Change	1.45%	2.59%	2.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$160.3M	$154.2M	$146.7M
YoY Change
Total Liabilities & Shareholders Equity	$302.8M	$246.3M	$239.7M
YoY Change	26.31%	5.96%	9.51%

Cashflow Statement

Concept	2024 Q2	2023 Q3
OPERATING ACTIVITIES
Net Income	$2.609M	$7.342M
YoY Change	-70.74%	-257.77%
Depreciation, Depletion And Amortization	$127.0K
YoY Change	53.01%
Cash From Operating Activities	-$8.320M	-$4.506M
YoY Change	74.25%	-271.57%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.937M	-373.8K
YoY Change	-139.64%	-91.19%
NET CHANGE
Cash From Operating Activities	-8.320M	-4.506M
Cash From Investing Activities
Cash From Financing Activities	-1.937M	-373.8K
Net Change In Cash	-10.26M	-4.880M
YoY Change	-9222.44%	202.21%
FREE CASH FLOW
Cash From Operating Activities	-$8.320M	-$4.506M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2090691	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-35040
	dei	Entity Registrant Name EntityRegistrantName	PHENIXFIN CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-4576073
	dei	Entity Address Address Line1 EntityAddressAddressLine1	445 Park Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	10th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(212)
	dei	Local Phone Number LocalPhoneNumber	859-0390
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2019778	shares
CY2024Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	233681365	usd
CY2023Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	226460691	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8866519	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5988223	usd
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	1715284	usd
CY2023Q3	us-gaap	Interest Receivable InterestReceivable	971115	usd
CY2024Q2	us-gaap	Dividends Receivable DividendsReceivable	215705	usd
CY2023Q3	us-gaap	Dividends Receivable DividendsReceivable	161479	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	205984	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	31425	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	649042	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	699124	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	410565	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	833000	usd
CY2024Q2	pfx	Prepaid Share Repurchases PrepaidShareRepurchases	101115	usd
CY2023Q3	pfx	Prepaid Share Repurchases PrepaidShareRepurchases	199019	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	3940175	usd
CY2024Q2	us-gaap	Assets Assets	246296757	usd
CY2023Q3	us-gaap	Assets Assets	239693465	usd
CY2024Q2	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1439916	usd
CY2023Q3	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1688835	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	85294535	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	84253106	usd
CY2024Q2	pfx	Payable For Investments Purchased PayableForInvestmentsPurchased	1834831	usd
CY2023Q3	pfx	Payable For Investments Purchased PayableForInvestmentsPurchased	4123059	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3789402	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	210753	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	232172	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3066984	usd
CY2024Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	520057	usd
CY2023Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	690398	usd
CY2024Q2	us-gaap	Other Liabilities OtherLiabilities	327045	usd
CY2023Q3	us-gaap	Other Liabilities OtherLiabilities	432698	usd
CY2024Q2	pfx	Administrator Expenses Payable AdministratorExpensesPayable	143936	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	421685	usd
CY2024Q2	us-gaap	Liabilities Liabilities	92093354	usd
CY2023Q3	us-gaap	Liabilities Liabilities	92987930	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2723709	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2723709	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2019778	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2073713	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	2021	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2074	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	692441333	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	694812239	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-538239951	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-548108778	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	154203403	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	146705535	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	246296757	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	239693465	usd
CY2024Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	76.35
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	70.75
CY2024Q2	us-gaap	Interest Income Operating InterestIncomeOperating	4198402	usd
CY2023Q2	us-gaap	Interest Income Operating InterestIncomeOperating	2722915	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	10593920	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	7938510	usd
CY2024Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	1514054	usd
CY2023Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	1926049	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	5180042	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	5461782	usd
CY2024Q2	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	147127	usd
CY2023Q2	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	95356	usd
	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	387501	usd
	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	313053	usd
CY2024Q2	us-gaap	Fee Income FeeIncome	375363	usd
CY2023Q2	us-gaap	Fee Income FeeIncome	94482	usd
	us-gaap	Fee Income FeeIncome	453988	usd
	us-gaap	Fee Income FeeIncome	339136	usd
	us-gaap	Other Income OtherIncome	22	usd
	us-gaap	Other Income OtherIncome	401986	usd
CY2024Q2	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	6234946	usd
CY2023Q2	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	4838802	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	16615473	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	14454467	usd
CY2024Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1721767	usd
CY2023Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1415102	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	4831180	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	4029874	usd
CY2024Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1514872	usd
CY2023Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1277797	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	4464372	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	2937420	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	432416	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	310878	usd
	us-gaap	Professional Fees ProfessionalFees	1133120	usd
	us-gaap	Professional Fees ProfessionalFees	1036024	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	226903	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	253298	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	862740	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	674456	usd
CY2024Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	187500	usd
CY2023Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	170833	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	562500	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	541333	usd
CY2024Q2	us-gaap	General Insurance Expense GeneralInsuranceExpense	95983	usd
CY2023Q2	us-gaap	General Insurance Expense GeneralInsuranceExpense	115654	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	290433	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	361125	usd
CY2024Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	75351	usd
CY2023Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	76351	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	210753	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	232172	usd
CY2024Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	4254792	usd
CY2023Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	3619913	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	12355098	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	9812404	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	1980154	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	1218889	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	210753	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	232172	usd
CY2024Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	4254792	usd
CY2023Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	3619913	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	12355098	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	9812404	usd
	us-gaap	Net Investment Income NetInvestmentIncome	4260375	usd
	us-gaap	Net Investment Income NetInvestmentIncome	4642063	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8698250	usd
CY2024Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	4254792	usd
CY2023Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	3619913	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	12355098	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	9812404	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	1218889	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8698250	usd
	us-gaap	Net Investment Income NetInvestmentIncome	4642063	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8698250	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1343368	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7137352	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2144717	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8069793	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	17079448	usd
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	628457	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1343368	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7137352	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8069793	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9041139	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1117025	usd
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	628457	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	7697771	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	8254377	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	14934731	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1343368	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2144717	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8069793	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1117025	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	17079448	usd
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	628457	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	7697771	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	14934731	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	2608611	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	8916660	usd
	us-gaap	Profit Loss ProfitLoss	12514752	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	7697771	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	8254377	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	14934731	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	2608611	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	8916660	usd
	us-gaap	Profit Loss ProfitLoss	12514752	usd
	us-gaap	Profit Loss ProfitLoss	19576794	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.26
CY2023Q2	us-gaap	Profit Loss ProfitLoss	8916660	usd
	us-gaap	Profit Loss ProfitLoss	19576794	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.34
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2019786	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2090691	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2047127	shares
	us-gaap	Profit Loss ProfitLoss	19576794	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.34
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2019786	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2090691	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2047127	shares
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	1218889	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.34
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2019786	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2090691	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2047127	shares
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	1218889	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2095591	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	131150889	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	1218889	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1343368	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9041139	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	112885	usd
CY2023Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-8803775	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	139954664	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1343368	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9041139	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	112885	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1343368	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9041139	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	112885	usd
CY2023Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-8803775	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	139954664	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	154271897	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	1980154	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8698250	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8069793	usd
CY2024Q2	pfx	Stock Issued During Period Value Distributions Declared StockIssuedDuringPeriodValueDistributionsDeclared	-2645925	usd
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	31180	usd
CY2024Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	68494	usd
CY2023Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-8803775	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	139954664	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	1980154	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	1980154	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8698250	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8069793	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8698250	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8069793	usd
CY2024Q2	pfx	Stock Issued During Period Value Distributions Declared StockIssuedDuringPeriodValueDistributionsDeclared	-2645925	usd
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	31180	usd
CY2024Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	68494	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	154203403	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	120845408	usd
	us-gaap	Net Investment Income NetInvestmentIncome	4642063	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2144717	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	17079448	usd
CY2024Q2	pfx	Stock Issued During Period Value Distributions Declared StockIssuedDuringPeriodValueDistributionsDeclared	-2645925	usd
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	31180	usd
CY2024Q2	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	68494	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	154203403	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	120845408	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2144717	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	17079448	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	467538	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-19109256	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	139954664	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	154203403	usd
	us-gaap	Net Investment Income NetInvestmentIncome	4642063	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	17079448	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	467538	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-19109256	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	139954664	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	467538	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-19109256	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	146705535	usd
	us-gaap	Net Investment Income NetInvestmentIncome	4260375	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	146705535	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	146705535	usd
	us-gaap	Net Investment Income NetInvestmentIncome	4260375	usd
	us-gaap	Net Investment Income NetInvestmentIncome	4260375	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7137352	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1117025	usd
	pfx	Stock Issued During Period Value Distributions Declared StockIssuedDuringPeriodValueDistributionsDeclared	-2645925	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	2370959	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-7497868	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	154203403	usd
	us-gaap	Profit Loss ProfitLoss	12514752	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7137352	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7137352	usd
	pfx	Stock Issued During Period Value Distributions Declared StockIssuedDuringPeriodValueDistributionsDeclared	-2645925	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	2370959	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-7497868	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	154203403	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1117025	usd
	pfx	Stock Issued During Period Value Distributions Declared StockIssuedDuringPeriodValueDistributionsDeclared	-2645925	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	2370959	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	154203403	usd
	us-gaap	Profit Loss ProfitLoss	12514752	usd
	us-gaap	Profit Loss ProfitLoss	12514752	usd
	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	87901740	usd
	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	85486774	usd
	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	49334640	usd
	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	1015546	usd
	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	716544	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	365717	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	505040	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	249913	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	286750	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	339587	usd
	us-gaap	Profit Loss ProfitLoss	19576794	usd
	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	87901740	usd
	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	39760986	usd
	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	87901740	usd
	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	49334640	usd
	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	85486774	usd
	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	49334640	usd
	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	1015546	usd
	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	1015546	usd
	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	716544	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	365717	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	505040	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	286750	usd
	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	716544	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	365717	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	249913	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	339587	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	339587	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	198530	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7137352	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2144717	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	1117025	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	198530	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7137352	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	198530	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	7137352	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2144717	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	1117025	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2144717	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	1117025	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	137882	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	41964	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	124457	usd
	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold	-3940175	usd
	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	54226	usd
	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	-48694	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-30157	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	17079448	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	137882	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	41964	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	124457	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	744169	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	137882	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	41964	usd
	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold	-3940175	usd
	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold	-3940175	usd
	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	54226	usd
	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable	-112500	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	174559	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-30157	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-97904	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-477713	usd
	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	54226	usd
	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	-48694	usd
	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable	-112500	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	174559	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-30157	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-97904	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-422435	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-97904	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-477713	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-577239	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-16550000	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-2288228	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	5118912	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	722418	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-22231	usd
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	183548	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-422435	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-577239	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-16550000	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-2288228	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	5118912	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	722418	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-22231	usd
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	183548	usd
	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	-143936	usd
	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	74911	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-577239	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-16550000	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-2288228	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	722418	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-22231	usd
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	183548	usd
	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	-143936	usd
	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	74911	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-170341	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	166452	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-421685	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-70301	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-105653	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-106449	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16222459	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	21178988	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	26521800	usd
	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	-143936	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-170341	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	166452	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-421685	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-70301	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-105653	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-106449	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16222459	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	32241942	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	21178988	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	26521800	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-170341	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	166452	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-421685	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-70301	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-105653	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-106449	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7393169	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16222459	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	21971498	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	21178988	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	26521800	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	994	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	289505	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	994	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	9752	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	289505	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	912274	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	2645925	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2370959	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	467538	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4514873	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	994	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	912274	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	2645925	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2370959	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	467538	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4514873	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4330578	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-11891881	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22768066	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8866519	usd
	us-gaap	Interest Paid Net InterestPaidNet	4365399	usd
	pfx	Noncash Purchase Of Investments NoncashPurchaseOfInvestments	45900000	usd
	pfx	Noncash Sale Of Investments NoncashSaleOfInvestments	45900000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates in the Preparation of Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8900000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6000000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	912274	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	2645925	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2370959	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4330578	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2878296	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-11891881	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5988223	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4330578	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2878296	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-11891881	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22768066	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8866519	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22768066	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8866519	usd
	us-gaap	Interest Paid Net InterestPaidNet	4365399	usd
	pfx	Noncash Purchase Of Investments NoncashPurchaseOfInvestments	45900000	usd
	pfx	Noncash Sale Of Investments NoncashSaleOfInvestments	45900000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10876185	usd
	us-gaap	Interest Paid Net InterestPaidNet	4365399	usd
	us-gaap	Interest Paid Net InterestPaidNet	2608928	usd
	pfx	Noncash Purchase Of Investments NoncashPurchaseOfInvestments	45900000	usd
	pfx	Noncash Sale Of Investments NoncashSaleOfInvestments	45900000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates in the Preparation of Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8900000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates in the Preparation of Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8900000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6000000	usd
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business, the Company enters into contractual agreements that provide general indemnifications against losses, costs, claims and liabilities arising from the performance of individual obligations under such agreements. The Company has had no material claims or payments pursuant to such agreements. The Company’s individual maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, based on management’s experience, the Company expects the risk of loss to be remote.</p>
CY2024Q2	us-gaap	Paid In Kind Interest PaidInKindInterest	600000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1000000	usd
CY2023Q2	us-gaap	Paid In Kind Interest PaidInKindInterest	200000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	700000	usd
CY2024Q2	us-gaap	Fee Income FeeIncome	400000	usd
CY2023Q2	us-gaap	Fee Income FeeIncome	100000	usd
	us-gaap	Fee Income FeeIncome	300000	usd
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	6900000	usd
CY2024Q2	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	3300000	usd
	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.014	pure
CY2023Q3	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	6500000	usd
CY2023Q3	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.029	pure
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business, the Company enters into contractual agreements that provide general indemnifications against losses, costs, claims and liabilities arising from the performance of individual obligations under such agreements. The Company has had no material claims or payments pursuant to such agreements. The Company’s individual maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, based on management’s experience, the Company expects the risk of loss to be remote.</p>
CY2024Q2	us-gaap	Paid In Kind Interest PaidInKindInterest	600000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1000000	usd
CY2023Q2	us-gaap	Paid In Kind Interest PaidInKindInterest	200000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	700000	usd
CY2024Q2	us-gaap	Fee Income FeeIncome	400000	usd
	us-gaap	Fee Income FeeIncome	500000	usd
CY2023Q2	us-gaap	Fee Income FeeIncome	100000	usd
	us-gaap	Fee Income FeeIncome	300000	usd
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	6900000	usd
CY2024Q2	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	3300000	usd
	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.014	pure
CY2023Q3	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.029	pure
	pfx	Percentage Of Investment Company Taxable Income PercentageOfInvestmentCompanyTaxableIncome	0.90	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.04	pure
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business, the Company enters into contractual agreements that provide general indemnifications against losses, costs, claims and liabilities arising from the performance of individual obligations under such agreements. The Company has had no material claims or payments pursuant to such agreements. The Company’s individual maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, based on management’s experience, the Company expects the risk of loss to be remote.</p>
CY2024Q2	us-gaap	Paid In Kind Interest PaidInKindInterest	600000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1000000	usd
CY2023Q2	us-gaap	Paid In Kind Interest PaidInKindInterest	200000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	700000	usd
CY2024Q2	us-gaap	Fee Income FeeIncome	400000	usd
CY2023Q2	us-gaap	Fee Income FeeIncome	100000	usd
	us-gaap	Fee Income FeeIncome	300000	usd
CY2024Q2	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	3300000	usd
	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.014	pure
CY2023Q3	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	6500000	usd
CY2023Q3	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.029	pure
	pfx	Percentage Of Investment Company Taxable Income PercentageOfInvestmentCompanyTaxableIncome	0.90	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.04	pure
	pfx	Distributable Ordinary Income Percentage DistributableOrdinaryIncomePercentage	0.98	pure
	pfx	Capital Gain Net Income Percentage CapitalGainNetIncomePercentage	0.982	pure
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	20600000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	23100000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20600000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23100000	usd
	pfx	Percentage Of Investment Company Taxable Income PercentageOfInvestmentCompanyTaxableIncome	0.90	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.04	pure
	pfx	Distributable Ordinary Income Percentage DistributableOrdinaryIncomePercentage	0.98	pure
	pfx	Capital Gain Net Income Percentage CapitalGainNetIncomePercentage	0.982	pure
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	20600000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	23100000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20600000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23100000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Company Investment Risk, Concentration of Credit Risk, and Liquidity Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has broad discretion in making investments. Investments generally consist of debt instruments that may be affected by business, financial market or legal uncertainties. Prices of investments may be volatile, and a variety of factors that are inherently difficult to predict, such as domestic or international economic and political developments, may significantly affect the results of the Company’s activities and the value of its investments. In addition, the value of the Company’s portfolio may fluctuate as the general level of interest rates fluctuate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of the Company’s investments in loans may be detrimentally affected to the extent, among other things, that a borrower defaults on its obligations, there is insufficient collateral and/or there are extensive legal and other costs incurred in collecting on a defaulted loan, observable secondary or primary market yields for similar instruments issued by comparable companies increase materially or risk premiums required in the market between smaller companies, such as our borrowers, and those for which market yields are observable increase materially.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s assets may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately. </p>
	pfx	Distributable Ordinary Income Percentage DistributableOrdinaryIncomePercentage	0.98	pure
	pfx	Capital Gain Net Income Percentage CapitalGainNetIncomePercentage	0.982	pure
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	20600000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	23100000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20600000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23100000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Company Investment Risk, Concentration of Credit Risk, and Liquidity Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has broad discretion in making investments. Investments generally consist of debt instruments that may be affected by business, financial market or legal uncertainties. Prices of investments may be volatile, and a variety of factors that are inherently difficult to predict, such as domestic or international economic and political developments, may significantly affect the results of the Company’s activities and the value of its investments. In addition, the value of the Company’s portfolio may fluctuate as the general level of interest rates fluctuate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of the Company’s investments in loans may be detrimentally affected to the extent, among other things, that a borrower defaults on its obligations, there is insufficient collateral and/or there are extensive legal and other costs incurred in collecting on a defaulted loan, observable secondary or primary market yields for similar instruments issued by comparable companies increase materially or risk premiums required in the market between smaller companies, such as our borrowers, and those for which market yields are observable increase materially.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s assets may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately. </p>
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	98400	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	206500	usd
CY2024Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	233681000	usd
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2023Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	226461000	usd
CY2023Q3	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	233681000	usd
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Company Investment Risk, Concentration of Credit Risk, and Liquidity Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has broad discretion in making investments. Investments generally consist of debt instruments that may be affected by business, financial market or legal uncertainties. Prices of investments may be volatile, and a variety of factors that are inherently difficult to predict, such as domestic or international economic and political developments, may significantly affect the results of the Company’s activities and the value of its investments. In addition, the value of the Company’s portfolio may fluctuate as the general level of interest rates fluctuate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of the Company’s investments in loans may be detrimentally affected to the extent, among other things, that a borrower defaults on its obligations, there is insufficient collateral and/or there are extensive legal and other costs incurred in collecting on a defaulted loan, observable secondary or primary market yields for similar instruments issued by comparable companies increase materially or risk premiums required in the market between smaller companies, such as our borrowers, and those for which market yields are observable increase materially.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s assets may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately. </p>
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	98400	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	206500	usd
CY2024Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	233681000	usd
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2023Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	226461000	usd
CY2023Q3	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	233681000	usd
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	226461000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	98400	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	206500	usd
CY2024Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	233681000	usd
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2023Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	226461000	usd
CY2023Q3	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	233681000	usd
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	226461000	usd
CY2023Q3	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
	us-gaap	Investment Income Net InvestmentIncomeNet	3324000	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	4385000	usd
	us-gaap	Operating Expenses OperatingExpenses	614000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	815000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2710000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3570000	usd
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	226461000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	3324000	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	4385000	usd
	us-gaap	Operating Expenses OperatingExpenses	614000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	815000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2710000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	165316000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	104750000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-110866000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Changes In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangesInUnrealizedGainLoss	-1218000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	-23559000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	141385000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	41632000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-33751000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	-816000	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	7400000	usd
CY2017Q3	pfx	Membership Interest Percentage MembershipInterestPercentage	0.05	pure
CY2017Q3	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	2400000	usd
CY2024Q2	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	0	usd
CY2023Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	0	usd
CY2018Q1	pfx	Asset Coverage Percentage With No Approval AssetCoveragePercentageWithNoApproval	2	pure
CY2024Q2	pfx	Asset Coverage Percentage AssetCoveragePercentage	2.778	pure
CY2023Q3	pfx	Asset Coverage Percentage AssetCoveragePercentage	2.707	pure
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	94088000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	86734000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	3324000	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	4385000	usd
	us-gaap	Operating Expenses OperatingExpenses	614000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	815000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2710000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	165316000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	104750000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-110866000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	6962000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Changes In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangesInUnrealizedGainLoss	-1218000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	-23559000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	146675000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	41632000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-33751000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	-816000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Changes In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangesInUnrealizedGainLoss	9477000	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	2100000	usd
CY2017Q3	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	2400000	usd
CY2024Q2	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	0	usd
CY2023Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	0	usd
CY2018Q1	pfx	Asset Coverage Percentage With No Approval AssetCoveragePercentageWithNoApproval	2	pure
CY2024Q2	pfx	Asset Coverage Percentage AssetCoveragePercentage	2.778	pure
CY2023Q3	pfx	Asset Coverage Percentage AssetCoveragePercentage	2.707	pure
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	94088000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	86734000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	85295000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	165316000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	104750000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-110866000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	6962000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Changes In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangesInUnrealizedGainLoss	-1218000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	-23559000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	141385000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	146675000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	41632000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-33751000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	-816000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Changes In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangesInUnrealizedGainLoss	9477000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	163217000	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	2100000	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	7400000	usd
CY2017Q3	pfx	Membership Interest Percentage MembershipInterestPercentage	0.05	pure
CY2017Q3	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	2400000	usd
CY2024Q2	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	0	usd
CY2023Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	0	usd
CY2018Q1	pfx	Asset Coverage Percentage With No Approval AssetCoveragePercentageWithNoApproval	2	pure
CY2024Q2	pfx	Asset Coverage Percentage AssetCoveragePercentage	2.778	pure
CY2023Q3	pfx	Asset Coverage Percentage AssetCoveragePercentage	2.707	pure
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	86734000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	85295000	usd
CY2024Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	81191000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	79058000	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	85942000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	84253000	usd
CY2023Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	77547000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P3Y
CY2022Q4	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1	50000000	usd
CY2024Q2	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	27600000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	28400000	usd
	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.029	pure
	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0025	pure
CY2023Q1	us-gaap	Securities Borrowed SecuritiesBorrowed	23200000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	22600000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	1	pure
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	85295000	usd
CY2024Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	81191000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	79058000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	84253000	usd
CY2023Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	77547000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P3Y
CY2022Q4	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1	50000000	usd
CY2024Q2	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	27600000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	28400000	usd
	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.029	pure
	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0025	pure
CY2023Q1	us-gaap	Securities Borrowed SecuritiesBorrowed	23200000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	22600000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	1	pure
CY2022Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	22521800	usd
CY2023Q3	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	1	pure
CY2024Q2	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.0525	pure
CY2024Q2	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	1661498	usd
CY2024Q2	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	739000	usd
CY2023Q2	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	477000	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1930000	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	830000	usd
CY2024Q2	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	17000	usd
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	48000	usd
CY2024Q2	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	127000	usd
CY2023Q2	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	83000	usd
	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	340000	usd
	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	199000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	83000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	83000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	249000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	287000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	1722000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	1415000	usd
	us-gaap	Interest Expense InterestExpense	4831000	usd
	us-gaap	Interest Expense InterestExpense	4030000	usd
CY2024Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	81191000	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	85942000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	84253000	usd
CY2023Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	77547000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P3Y
CY2022Q4	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1	50000000	usd
CY2024Q2	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	27600000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	28400000	usd
	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.029	pure
	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0025	pure
CY2023Q1	us-gaap	Securities Borrowed SecuritiesBorrowed	23200000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	22600000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	1	pure
CY2022Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	22521800	usd
CY2023Q3	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	1	pure
CY2024Q2	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.0525	pure
CY2024Q2	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	1661498	usd
CY2024Q2	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	739000	usd
CY2023Q2	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	477000	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1930000	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	830000	usd
CY2024Q2	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	17000	usd
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	48000	usd
CY2024Q2	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	127000	usd
CY2023Q2	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	83000	usd
	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	340000	usd
	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	199000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	83000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	83000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	287000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	1722000	usd
	us-gaap	Interest Expense InterestExpense	4831000	usd
	us-gaap	Interest Expense InterestExpense	4030000	usd
CY2024Q2	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.064	pure
CY2023Q2	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.06	pure
	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.063	pure
CY2022Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	22521800	usd
CY2023Q3	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	1	pure
CY2024Q2	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.0525	pure
CY2024Q2	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	1661498	usd
CY2024Q2	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	739000	usd
CY2023Q2	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	477000	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1930000	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	830000	usd
CY2024Q2	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	17000	usd
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	48000	usd
CY2024Q2	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	127000	usd
CY2023Q2	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	83000	usd
	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	340000	usd
	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	199000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	83000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	83000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	249000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	287000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	1722000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	1415000	usd
	us-gaap	Interest Expense InterestExpense	4831000	usd
	us-gaap	Interest Expense InterestExpense	4030000	usd
CY2024Q2	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.064	pure
CY2023Q2	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.06	pure
	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.063	pure
	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.058	pure
CY2024Q2	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	94127000	usd
CY2023Q2	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	83061000	usd
	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	88660000	usd
	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.063	pure
	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.058	pure
CY2024Q2	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	94127000	usd
	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	88660000	usd
	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	81227000	usd
CY2024Q2	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	684735	usd
	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	1494425	usd
	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	159000	usd
	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	2941000	usd
CY2023	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	3375000	usd
	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The lease commenced September 1, 2021 and expires November 30, 2026.
CY2024Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P2Y
CY2023Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	41159	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	156971	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	161680	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	27417	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	60182	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	327045	usd
CY2024Q2	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	94127000	usd
CY2023Q2	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	83061000	usd
	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	88660000	usd
CY2024Q2	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	684735	usd
	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	1494425	usd
CY2023Q2	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	159000	usd
	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	159000	usd
	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	2941000	usd
CY2023	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	3375000	usd
	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The lease commenced September 1, 2021 and expires November 30, 2026.
CY2024Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P2Y
CY2023Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	41159	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	156971	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	161680	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	27417	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	60182	usd
CY2024Q2	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	684735	usd
	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	159000	usd
	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	2941000	usd
CY2023	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	3375000	usd
	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The lease commenced September 1, 2021 and expires November 30, 2026.
CY2024Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P2Y
CY2023Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	41159	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	156971	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	161680	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	27417	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	387227	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	327045	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	327045	usd
	pfx	Administrative Agent Fee AdministrativeAgentFee	75000	usd
	pfx	Administrative Agent Fee AdministrativeAgentFee	169000	usd
CY2024Q2	us-gaap	Payments For Fees PaymentsForFees	375000	usd
CY2023Q2	us-gaap	Payments For Fees PaymentsForFees	94000	usd
	us-gaap	Payments For Fees PaymentsForFees	379000	usd
	us-gaap	Payments For Fees PaymentsForFees	170000	usd
CY2024Q2	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	375000	usd
CY2023Q2	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	94000	usd
	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	454000	usd
CY2024Q2	us-gaap	Other Expenses OtherExpenses	200000	usd
	us-gaap	Other Expenses OtherExpenses	600000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	2609000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	8917000	usd
	us-gaap	Profit Loss ProfitLoss	12515000	usd
	us-gaap	Profit Loss ProfitLoss	19577000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2019786	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2090691	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2047127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2095591	shares
	pfx	Administrative Agent Fee AdministrativeAgentFee	75000	usd
	pfx	Administrative Agent Fee AdministrativeAgentFee	169000	usd
CY2024Q2	us-gaap	Payments For Fees PaymentsForFees	375000	usd
CY2023Q2	us-gaap	Payments For Fees PaymentsForFees	94000	usd
	us-gaap	Payments For Fees PaymentsForFees	379000	usd
	us-gaap	Payments For Fees PaymentsForFees	170000	usd
CY2024Q2	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	375000	usd
CY2023Q2	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	94000	usd
	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	454000	usd
	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	339000	usd
CY2024Q2	us-gaap	Other Expenses OtherExpenses	200000	usd
	us-gaap	Other Expenses OtherExpenses	600000	usd
CY2023Q2	us-gaap	Other Expenses OtherExpenses	200000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	2609000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	8917000	usd
	us-gaap	Profit Loss ProfitLoss	12515000	usd
	us-gaap	Profit Loss ProfitLoss	19577000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2019786	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2090691	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2047127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2095591	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.34
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.49
	pfx	Administrative Agent Fee AdministrativeAgentFee	75000	usd
	pfx	Administrative Agent Fee AdministrativeAgentFee	169000	usd
CY2024Q2	us-gaap	Payments For Fees PaymentsForFees	375000	usd
CY2023Q2	us-gaap	Payments For Fees PaymentsForFees	94000	usd
	us-gaap	Payments For Fees PaymentsForFees	379000	usd
CY2024Q2	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	375000	usd
CY2023Q2	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	94000	usd
CY2024Q2	us-gaap	Other Expenses OtherExpenses	200000	usd
CY2023Q2	us-gaap	Other Expenses OtherExpenses	200000	usd
	us-gaap	Other Expenses OtherExpenses	500000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	8917000	usd
	us-gaap	Profit Loss ProfitLoss	12515000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2019786	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2047127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2095591	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.11
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.49
	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	3.49
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.26
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	70.75
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.49
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	2.08
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	2.22
	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	3.49
	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	-1.02
	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	0.54
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	6.11
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	9.34
	pfx	Distributions Declaredinshares DistributionsDeclaredinshares	-1.31
	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.8
	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.18
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.51
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.18
CY2024Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	76.35
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	67.01
CY2024Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	154203403	usd
CY2023Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	139954664	usd
CY2024Q2	us-gaap	Shares Outstanding SharesOutstanding	2019778	shares
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	2088589	shares
CY2024Q2	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	46.77
CY2023Q2	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	38
	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	0.2686	pure
	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	0.0894	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0691	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1656	pure
	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.379	pure
	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.2033	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0376	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0494	pure
	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.109	pure
	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1045	pure
	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0235	pure
	pfx	Average Debt Outstanding AverageDebtOutstanding	88660220	shares
	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	43.31
	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	38.85
	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2778	usd
	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2632	usd
	pfx	Supplemental Data Credit Facility SupplementalDataCreditFacility	27572953	usd
	pfx	Supplemental Data Credit Facility SupplementalDataCreditFacility	28241941	usd
CY2024Q2	us-gaap	Investment Company Senior Security Stock Asset Coverage Ratio InvestmentCompanySeniorSecurityStockAssetCoverageRatio	2.778	pure
	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	3.49
	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	-1.02
	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	0.54
	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	8.14
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	6.11
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	9.34
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.18
CY2024Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	76.35
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	67.01
CY2024Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	154203403	usd
CY2023Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	139954664	usd
CY2024Q2	us-gaap	Shares Outstanding SharesOutstanding	2019778	shares
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	2088589	shares
CY2024Q2	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	46.77
CY2023Q2	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	38
	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	0.2686	pure
	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	0.0894	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0691	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1656	pure
	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.379	pure
	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.2033	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0376	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0494	pure
	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.109	pure
	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1045	pure
	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0235	pure
	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	43.31
	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2778	usd
	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2632	usd
	pfx	Supplemental Data Credit Facility SupplementalDataCreditFacility	27572953	usd
	pfx	Supplemental Data Credit Facility SupplementalDataCreditFacility	28241941	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	1000	usd
CY2024Q2	us-gaap	Investment Company Senior Security Stock Asset Coverage Ratio InvestmentCompanySeniorSecurityStockAssetCoverageRatio	2.778	pure
CY2024Q2	us-gaap	Investment Company Senior Security Indebtedness Asset Coverage Ratio InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio	2	pure
CY2024Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1.31
CY2024Q2	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	28100000	usd
CY2024Q2	pfx	Percentage Of Shares Outstanding PercentageOfSharesOutstanding	0.258	pure
CY2024Q2	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	6900000	usd
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	703931	shares
	pfx	Aggregate Consideration For Repurchased Shares AggregateConsiderationForRepurchasedShares	28108445	shares
	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	-1.02
	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	0.54
	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	8.14
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	6.11
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	9.34
	pfx	Distributions Declaredinshares DistributionsDeclaredinshares	-1.31
	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.18
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.51
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.18
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	67.01
CY2024Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	154203403	usd
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	2088589	shares
CY2024Q2	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	46.77
CY2023Q2	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	38
	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	0.2686	pure
	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	0.0894	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0691	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1656	pure
	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.379	pure
	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.2033	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0376	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0494	pure
	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.109	pure
	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1045	pure
	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0273	pure
	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0235	pure
	pfx	Average Debt Outstanding AverageDebtOutstanding	88660220	shares
	pfx	Average Debt Outstanding AverageDebtOutstanding	81227306	shares
	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	43.31
	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	38.85
	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2778	usd
	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2632	usd
	pfx	Supplemental Data Credit Facility SupplementalDataCreditFacility	27572953	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	1000	usd
CY2024Q2	us-gaap	Investment Company Senior Security Stock Asset Coverage Ratio InvestmentCompanySeniorSecurityStockAssetCoverageRatio	2.778	pure
CY2024Q2	us-gaap	Investment Company Senior Security Indebtedness Asset Coverage Ratio InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio	2	pure
CY2024Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1.31
CY2024Q2	pfx	Percentage Of Shares Outstanding PercentageOfSharesOutstanding	0.258	pure
CY2024Q2	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	6900000	usd
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	703931	shares
CY2024Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1.31
CY2021Q1	srt	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	703931	shares
CY2024Q2	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	28100000	usd
CY2024Q2	pfx	Percentage Of Shares Outstanding PercentageOfSharesOutstanding	0.258	pure
CY2024Q2	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	6900000	usd
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	703931	shares
	pfx	Aggregate Consideration For Repurchased Shares AggregateConsiderationForRepurchasedShares	28108445	shares
	pfx	Stock Transferred To Treasury Stock StockTransferredToTreasuryStock	54048	shares
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	125	shares
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
CY2023Q3	pfx	Administrator Expenses Payable AdministratorExpensesPayable		usd
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent		usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.34
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2047127	shares
	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold		usd
	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates		usd
	pfx	Noncash Sale Of Investments NoncashSaleOfInvestments		usd
	pfx	Aggregate Consideration For Repurchased Shares AggregateConsiderationForRepurchasedShares	28108445	shares
	pfx	Stock Transferred To Treasury Stock StockTransferredToTreasuryStock	54048	shares
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	125	shares
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
CY2023Q3	pfx	Administrator Expenses Payable AdministratorExpensesPayable		usd
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent		usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2019786	shares
CY2024Q2	us-gaap	Other Income OtherIncome		usd
CY2023Q2	us-gaap	Other Income OtherIncome		usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.34
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2095591	shares
	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold		usd
	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates		usd
	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
	pfx	Noncash Sale Of Investments NoncashSaleOfInvestments		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet		usd
CY2023Q2	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts		usd
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts		usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2024Q2	pfx	Prepayment Fee PrepaymentFee		usd
CY2023Q2	pfx	Prepayment Fee PrepaymentFee		usd
	pfx	Prepayment Fee PrepaymentFee		usd
	pfx	Prepayment Fee PrepaymentFee		usd
CY2024Q2	pfx	Administrative Agent Fee AdministrativeAgentFee		usd
CY2023Q2	pfx	Administrative Agent Fee AdministrativeAgentFee		usd
CY2023Q2	pfx	Amendment Fee Income AmendmentFeeIncome		usd
	pfx	Amendment Fee Income AmendmentFeeIncome		usd
	pfx	Amendment Fee Income AmendmentFeeIncome		usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2047127	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2090691	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2095591	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.11
	pfx	Stock Transferred To Treasury Stock StockTransferredToTreasuryStock	54048	shares
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	125	shares
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
CY2023Q3	pfx	Administrator Expenses Payable AdministratorExpensesPayable		usd
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent		usd
CY2024Q2	us-gaap	Other Income OtherIncome		usd
CY2023Q2	us-gaap	Other Income OtherIncome		usd
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.34
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2019786	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2095591	shares
	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold		usd
	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates		usd
	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
	pfx	Noncash Purchase Of Investments NoncashPurchaseOfInvestments		usd
	pfx	Noncash Sale Of Investments NoncashSaleOfInvestments		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet		usd
CY2023Q2	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts		usd
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts		usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2024Q2	pfx	Prepayment Fee PrepaymentFee		usd
CY2023Q2	pfx	Prepayment Fee PrepaymentFee		usd
	pfx	Prepayment Fee PrepaymentFee		usd
CY2024Q2	pfx	Administrative Agent Fee AdministrativeAgentFee		usd
CY2024Q2	pfx	Amendment Fee Income AmendmentFeeIncome		usd
CY2023Q2	pfx	Amendment Fee Income AmendmentFeeIncome		usd
	pfx	Amendment Fee Income AmendmentFeeIncome		usd
	pfx	Amendment Fee Income AmendmentFeeIncome		usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2019786	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2047127	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2090691	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2095591	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.34
	pfx	Distributions Declaredinshares DistributionsDeclaredinshares
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet		usd
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts		usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2024Q2	pfx	Prepayment Fee PrepaymentFee		usd
CY2023Q2	pfx	Prepayment Fee PrepaymentFee		usd
	pfx	Prepayment Fee PrepaymentFee		usd
	pfx	Prepayment Fee PrepaymentFee		usd
CY2024Q2	pfx	Administrative Agent Fee AdministrativeAgentFee		usd
CY2023Q2	pfx	Administrative Agent Fee AdministrativeAgentFee		usd
CY2024Q2	pfx	Amendment Fee Income AmendmentFeeIncome		usd
CY2023Q2	pfx	Amendment Fee Income AmendmentFeeIncome		usd
	pfx	Amendment Fee Income AmendmentFeeIncome		usd
	pfx	Amendment Fee Income AmendmentFeeIncome		usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2019786	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2047127	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2090691	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2095591	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.34
	pfx	Distributions Declaredinshares DistributionsDeclaredinshares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.34
	pfx	Distributions Declaredinshares DistributionsDeclaredinshares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001490349
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001490349

Files In Submission

Name	View Source	Status
0001213900-24-065749-index-headers.html	Edgar Link	pending
0001213900-24-065749-index.html	Edgar Link	pending
0001213900-24-065749.txt	Edgar Link	pending
0001213900-24-065749-xbrl.zip	Edgar Link	pending
ea0210151-10q_phenixfin.htm	Edgar Link	pending
ea021015101ex31-1_phenix.htm	Edgar Link	pending
ea021015101ex31-2_phenix.htm	Edgar Link	pending
ea021015101ex32-1_phenix.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pfx-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
pfx-20240630_cal.xml	Edgar Link	unprocessable
ea0210151-10q_phenixfin_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pfx-20240630_lab.xml	Edgar Link	unprocessable
pfx-20240630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
pfx-20240630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PFX
PhenixFIN Corp Stock $pfx

2024 Q3 Form 10-Q Financial Statement

#000121390024065749 Filed on August 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFX PhenixFIN Corp Stock $pfx

2024 Q3 Form 10-Q Financial Statement

#000121390024065749 Filed on August 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFX
PhenixFIN Corp Stock $pfx